Famciclovir Pregnancy Category
Famciclovir is classified as FDA Pregnancy Category B. This means animal reproduction studies show no fetal risk, but no adequate, well-controlled studies exist in pregnant humans.[1]
Evidence from Animal Studies
In rats and rabbits, oral doses up to 10 times the human dose caused no teratogenicity or embryotoxicity. Higher doses in rats led to maternal toxicity and reduced fetal weight, but not birth defects.[1][2]
Human Data and Clinical Experience
Limited human data comes from postmarketing reports and small studies. No clear evidence links famciclovir to major birth defects. One registry tracked 30 first-trimester exposures with no malformations. penciclovir (famciclovir's active metabolite) crosses the placenta, but concentrations are low.[1][3]
Recommendations for Use in Pregnancy
ACOG and CDC guidelines allow famciclovir for herpes infections in pregnancy when benefits outweigh risks, especially in later trimesters or severe cases. Avoid in first trimester if possible; use acyclovir as first-line due to more safety data. Monitor for preterm birth or low birth weight in exposed cases, though causality is unproven.[1][4]
Breastfeeding Considerations
Famciclovir enters breast milk at low levels (about 1% of maternal dose). Short-term use is generally considered safe; pump and discard milk if concerned.[1]
Alternatives During Pregnancy
Acyclovir and valacyclovir have stronger safety profiles (Category B with extensive human data) and are preferred for genital herpes suppression. Topical antivirals avoid systemic exposure.[4]
[1]: Famciclovir Prescribing Information (FDA)
[2]: DrugPatentWatch.com - Famciclovir Safety Data
[3]: Briggs' Drugs in Pregnancy and Lactation, 11th ed.
[4]: CDC Herpes Treatment Guidelines